Swiss biotech company Asceneuron said on Tuesday it had raised $100 million from investors including the controlling shareholder of Wegovy maker Novo Nordisk to fund clinical development of its Alzheimer’s disease drug.
Tag Archive for: Novo Holdings
Novo Holdings announced today that it is buying a majority stake in the Austrian life sciences tools company Single Use Support, a provider of fluid management services.
The foundation receives its funds from the wholly owned subsidiary Novo Holdings, through which it controls Wegovy maker Novo Nordisk as well as other companies.
The CEO of Novo Holdings said on Tuesday the controlling shareholder of Danish drugmaker Novo Nordisk is ready for a huge windfall from the runaway success of weight-loss drug Wegovy.